Mount Sinai Heart - Topics In Cardiology

Tuesday, October 16, 2018, 6:30 PM - 9:45 PM, Dee's Restaurant


The latest in a continuing series of outreach CME programs designed to update primary care practitioners in the central Queens community with regard to the latest developments in cardiology and to assist in enhancing the integration of these advances into their clinical practices for better patient.

1. - Assess various approaches to mitral insufficiency and the indications for percutaneous mitral valve interventions in order to identify those patients in whom they would be beneficial
2. - Restate the spectrum of patients with renal artery stenosis, and the underlying pathophysiology, to identify those subsets in whom revascularization is likely to be beneficial as well as those for which no intervention is indicated.
3. - Review current guidelines for the pre-operative testing of cardiac patients undergoing non-cardiac surgery in order to improve outcomes and yet minimize unnecessary testing.

Registration is complimentary and must be completed online

Registrants, who have not visited CloudCME before, must first create a CloudCME profile

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation
The Icahn School of Medicine at Mount Sinai designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Verification of Attendance
Will be provided to all professionals, upon request.

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Attendance (2.00 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course materials.

Course Director
MICHAEL J. ROBBINS, MD
Associate Professor of Medicine
Icahn School of Medicine at Mount Sinai
Mount Sinai Heart

Tuesday, October 16, 2018